- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
In vitro drug testing using patient-derived ovarian cancer organoids ; volume:17 ; number:1 ; day:2 ; month:10 ; year:2024 ; pages:1-12 ; date:12.2024
Journal of ovarian research ; 17, Heft 1 (2.10.2024), 1-12, 12.2024
- Creator
-
Chen, Lin-Yu
Chou, Yu-Ting
Liew, Phui-Ly
Chu, Ling-Hui
Wen, Kuo-Chang
Lin, Shiou-Fu
Weng, Yu-Chun
Wang, Hui-Chen
Su, Po-Hsuan
Lai, Hung-Cheng
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13048-024-01520-2
- URN
-
urn:nbn:de:101:1-2502192102241.037081847468
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chen, Lin-Yu
- Chou, Yu-Ting
- Liew, Phui-Ly
- Chu, Ling-Hui
- Wen, Kuo-Chang
- Lin, Shiou-Fu
- Weng, Yu-Chun
- Wang, Hui-Chen
- Su, Po-Hsuan
- Lai, Hung-Cheng
- SpringerLink (Online service)
Other Objects (12)
Correction: In vitro drug testing using patient-derived ovarian cancer organoids
High-content image analysis of patient-derived organoids
Ultrastructural analysis of breast cancer patient-derived organoids
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids
Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine
Drug interactions and response in patient-derived colorectal cancer organoids
T cell-mediated cytotoxicity against patient-derived cervical cancer organoids
Applications of patient-derived tumor xenograft models and tumor organoids
Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids
Modelling of primary ciliary dyskinesia using patient‐derived airway organoids
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies
The role of patient-derived ovarian cancer organoids in the study of PARP inhibitors sensitivity and resistance: from genomic analysis to functional testing
Correction: In vitro drug testing using patient-derived ovarian cancer organoids
High-content image analysis of patient-derived organoids
Ultrastructural analysis of breast cancer patient-derived organoids
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids
Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine
Drug interactions and response in patient-derived colorectal cancer organoids
T cell-mediated cytotoxicity against patient-derived cervical cancer organoids
Applications of patient-derived tumor xenograft models and tumor organoids
Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids
Modelling of primary ciliary dyskinesia using patient‐derived airway organoids
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies
The role of patient-derived ovarian cancer organoids in the study of PARP inhibitors sensitivity and resistance: from genomic analysis to functional testing
Correction: In vitro drug testing using patient-derived ovarian cancer organoids
High-content image analysis of patient-derived organoids
Ultrastructural analysis of breast cancer patient-derived organoids
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids
Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine
Drug interactions and response in patient-derived colorectal cancer organoids
T cell-mediated cytotoxicity against patient-derived cervical cancer organoids
Applications of patient-derived tumor xenograft models and tumor organoids
Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids
Modelling of primary ciliary dyskinesia using patient‐derived airway organoids
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies